Flagship Wealth Advisors’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5K Buy
+361
New +$12.9K ﹤0.01% 368

Other funds holding TEVA

Flagship Wealth Advisors's TEVA Position: Q3 2026 in Review

Flagship Wealth Advisors opened a new position in Teva Pharmaceutical Industries (TEVA) in Q3 2026: 361 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #368 among its holdings.

598 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Flagship Wealth Advisors held 361 shares of Teva Pharmaceutical Industries worth $14.5K as of Q3 2026.
  • Teva Pharmaceutical Industries was a new Flagship Wealth Advisors position in Q3 2026.
  • Teva Pharmaceutical Industries made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #368 holding.
  • 598 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.